Altfest L J & CO Inc Amgen Inc Transaction History

Altfest L J & CO Inc

$751 Million
Q3 2024

A detailed history of Altfest L J & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Altfest L J & CO Inc holds 5,338 shares of AMGN stock, worth $1.57 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

5,338

Previous 5,336 0.04%

Holding current value

$1.57 Million

Previous $1.67 Million 3.18%

% of portfolio

0.23%

Previous 0.23%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $618 - $674	2 Added 0.04%	5,338 $1.72 Million
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $135,053 - $164,125	514 Added 10.66%	5,336 $1.67 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $270,483 - $326,507	1,006 Added 26.36%	4,822 $1.37 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $29,916 - $33,749	-117 Reduced 2.97%	3,816 $1.1 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $9,839 - $12,215	45 Added 1.16%	3,933 $1.06 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $34,283 - $40,539	-160 Reduced 3.95%	3,888 $863,000
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $7,902 - $9,632	-35 Reduced 0.86%	4,048 $979,000
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $13,512 - $17,169	-59 Reduced 1.42%	4,083 $1.07 Million
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $15,487 - $17,467	69 Added 1.69%	4,142 $934,000
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $1,614 - $1,797	-7 Reduced 0.17%	4,073 $991,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $519,012 - $574,163	-2,367 Reduced 36.71%	4,080 $987,000
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $7,557 - $8,648	-38 Reduced 0.59%	6,447 $1.45 Million
Q3 2021 Oct 12, 2021	BUY	$212.27 - $248.7 $503,716 - $590,165	2,373 Added 57.71%	6,485 $1.38 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $2,335 - $2,591	-10 Reduced 0.24%	4,112 $1 Million
Q1 2021 May 07, 2021	SELL	$221.91 - $258.6 $168,651 - $196,536	-760 Reduced 15.57%	4,122 $1.03 Million
Q4 2020 Jan 21, 2021	BUY	$216.38 - $257.67 $164,448 - $195,829	760 Added 18.44%	4,882 $1.12 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $242,393 - $269,561	-1,033 Reduced 20.04%	4,122 $1.05 Million
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $106,223 - $130,351	537 Added 11.63%	5,155 $1.22 Million
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $4,009 - $5,317	22 Added 0.48%	4,618 $936,000
Q4 2019 Jan 06, 2020	SELL	$189.21 - $243.2 $4,730 - $6,080	-25 Reduced 0.54%	4,596 $1.11 Million
Q3 2019 Oct 10, 2019	SELL	$174.11 - $208.62 $315,835 - $378,436	-1,814 Reduced 28.19%	4,621 $894,000
Q2 2019 Jul 15, 2019	BUY	$166.7 - $195.41 $268,720 - $315,000	1,612 Added 33.42%	6,435 $1.19 Million
Q1 2019 Jun 10, 2019	SELL	$180.87 - $203.88 $11,575 - $13,048	-64 Reduced 1.31%	4,823 $916,000
Q1 2019 May 24, 2019	SELL	$180.87 - $203.88 $492,147 - $554,757	-2,721 Reduced 35.76%	4,887 $951,000
Q1 2019 Apr 05, 2019	BUY	$180.87 - $203.88 $1.38 Million - $1.55 Million	7,608 New	7,608 $983,000
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $879,690 - $1.03 Million	-4,931 Closed	0 $0
Q3 2018 Oct 10, 2018	SELL	$185.29 - $208.89 $103,577 - $116,769	-559 Reduced 10.18%	4,931 $1.02 Million
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $84,851 - $95,306	-511 Reduced 8.52%	5,490 $1.01 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $12,029 - $14,058	71 Added 1.2%	6,001 $1.02 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $1.2 Million - $1.34 Million	-7,127 Reduced 54.58%	5,930 $1.03 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $2.18 Million - $2.49 Million	13,057	13,057 $2.43 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.

Account